S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants

Evelo Biosciences (EVLO) SEC Filings & 10K Form

$0.06
+0.01 (+18.23%)
(As of 03/1/2024 08:53 PM ET)

Recent Evelo Biosciences SEC Filings

DateFilerForm TypeView
01/26/2024
4:26 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
4:27 PM
Evelo Biosciences (Filer)
Form POS AM
01/26/2024
4:28 PM
Evelo Biosciences (Filer)
Form S-8 POS
01/26/2024
4:29 PM
Evelo Biosciences (Filer)
Form S-8 POS
01/26/2024
4:30 PM
Evelo Biosciences (Filer)
Form 15-12G
12/27/2023
8:02 AM
Evelo Biosciences (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
12/12/2023
6:42 AM
Evelo Biosciences (Filer)
Form DEF 14A
12/12/2023
6:43 AM
Evelo Biosciences (Filer)
Form DEFA14A
12/11/2023
8:09 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/04/2023
5:04 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
6:11 AM
Evelo Biosciences (Filer)
Form PRE 14A
11/21/2023
5:44 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:02 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2023
7:31 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:31 PM
Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:32 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:32 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
4:24 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
6:05 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
7:54 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
7:55 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
7:55 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
4:25 PM
Evelo Biosciences (Filer)
Form 424B3
08/21/2023
6:43 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
11:15 PM
Evelo Biosciences (Filer)
Form EFFECT
08/14/2023
7:14 AM
Evelo Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:42 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:19 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G
08/09/2023
7:44 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:42 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:42 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:43 PM
Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
6:21 PM
Evelo Biosciences (Issuer)
Horizon Technology Finance Corp (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/21/2023
2:46 PM
Evelo Biosciences (Subject)
Horizon Technology Finance Corp (Filed by)
Form SC 13G
07/21/2023
7:00 AM
Evelo Biosciences (Subject)
HarbourVest Partners L.P. (Filed by)
Form SC 13G
07/20/2023
3:21 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
4:15 PM
AFEYAN NOUBAR (Reporting)
Evelo Biosciences (Issuer)
Flagship Pioneering Fund VII General Partner LLC (Reporting)
Flagship Pioneering Fund VII, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Flagship Ventures Fund IV General Partner LLC (Reporting)
Flagship Ventures Fund IV, L.P. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:03 PM
Evelo Biosciences (Issuer)
Moore Jeffrey R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
3:05 PM
Evelo Biosciences (Issuer)
Moore Jeffrey R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:06 PM
Evelo Biosciences (Issuer)
Reynolds Alexander C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
3:08 PM
Evelo Biosciences (Issuer)
Reynolds Alexander C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
6:55 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
9:20 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/10/2023
6:36 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:06 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
4:10 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:54 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:09 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
7:21 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
05/22/2023
5:33 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
3:43 PM
Evelo Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2023
8:31 PM
Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:31 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:31 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:32 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
6:11 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2023
4:24 PM
Evelo Biosciences (Filer)
Form PRE 14A
04/18/2023
4:10 PM
Evelo Biosciences (Issuer)
Rosiello Robert L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2023
4:12 PM
Evelo Biosciences (Issuer)
Rosiello Robert L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2023
7:27 AM
Evelo Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/16/2023
6:10 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EVLO) was last updated on 3/4/2024 by MarketBeat.com Staff